AZmed is proud to be listed in the "Mapping des startups françaises de l’IA"

SimonMed Imaging, a leading name in outpatient imaging centers in the United States, has selected AZmed as its AI partner for X-ray diagnostics. This strategic collaboration aims to enhance efficiency, reduce waiting times, and elevate patient care standards through the integration of Rayvolve, AZmed's AI solution.

SimonMed Imaging recognized the pressing need for advanced AI assistance in managing the increasing volume of X-rays. After a thorough audit of various companies in the space, SimonMed opted for a trial of Rayvolve. The subsequent success and satisfaction among radiologists were validated, focusing on the remarkable improvement in Turnaround Time (TAT).

European MedTech startup AZmed, recognized as a leading company in AI for medical imaging, today announced that its Rayvolve solution has received 510(k) clearance from the Food and Drug Administration (FDA) for detecting fractures on pediatric X-rays. This milestone comes two years after receiving FDA clearance for adult fracture detection, positioning Rayvolve as a top-performing solution for detecting fractures in adult and pediatric patients. The clearance was supported by an independent study conducted with SimonMed Imaging, one of the largest outpatient imaging providers in the U.S.

AZmed, a leading European MedTech startup, has secured €15 million in Series A funding. The operation includes investors such as Maison Worms, Techstars, and Teampact Ventures. The investment supports AZmed's overarching objective of shaping the future of medical imaging with artificial intelligence by accelerating the workflows of radiologists.